Sanbo Brain Hospital, Capital Medical University
Sanbo Brain Hospital, Capital Medical University
Beijing, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IN10018 in Combination With Dalpiciclib for Progressive Meningiomas | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Phase 1 | 2026-08-07 | NCT07652762 | |
| Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation | Residual or Recurrent Grade 2 IDH Mutant Glioma | Active, not recruiting | Phase 3 | 2026-06-04 | NCT06780930 |